Validity and reliability of the Rosacea Area and Severity Index: A novel scoring system for clinical assessment of rosacea severity

Rosacea is a common chronic inflammatory facial skin disorder. Standardized evaluation of the severity and extent of rosacea is important for baseline assessment and treatment effect. The currently used Investigator's Global Assessment (IGA) is unspecific and fails to consider subtypes/phenotypes of rosacea and area involvement. The Rosacea Area and Severity Index (RASI) was developed to give a more nuanced evaluation of rosacea features in four facial skin areas adjusted to the relative importance of each area of the face to obtain an overall severity score.

[1]  J. Thyssen,et al.  Clinical characteristics of combined rosacea and migraine , 2022, Frontiers in Medicine.

[2]  Matthijs J. Warrens,et al.  A Comparison of Reliability Coefficients for Ordinal Rating Scales , 2021, Journal of Classification.

[3]  J. Thyssen,et al.  Incidence and prevalence of rosacea: a systematic review and meta‐analysis , 2018, The British journal of dermatology.

[4]  M. Schaller,et al.  Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel , 2017, The British journal of dermatology.

[5]  Terry K Koo,et al.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. , 2016, Journal Chiropractic Medicine.

[6]  A. Bewley,et al.  Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis , 2016, Dermatology and Therapy.

[7]  J. Thyssen,et al.  Patients with Rosacea Have Increased Risk of Depression and Anxiety Disorders: A Danish Nationwide Cohort Study , 2016, Dermatology.

[8]  S. Feldman,et al.  The psychological impact of rosacea and the influence of current management options. , 2014, Journal of the American Academy of Dermatology.

[9]  M. Chren,et al.  A pilot quality-of-life instrument for acne rosacea. , 2007, Journal of the American Academy of Dermatology.

[10]  T. Agner,et al.  The hand eczema severity index (HECSI): a scoring system for clinical assessment of hand eczema. A study of inter‐ and intraobserver reliability , 2005, The British journal of dermatology.

[11]  A. Feinstein,et al.  Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. , 2002, Journal of the American Academy of Dermatology.

[12]  M. Graeber,et al.  The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis , 2001, Experimental dermatology.

[13]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[14]  Diane Thiboutot,et al.  Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee , 2018, Journal of the American Academy of Dermatology.

[15]  V. Preedy,et al.  Dermatology Life Quality Index , 2010 .

[16]  Lidija Bilić-Zulle,et al.  [Correlation and regression]. , 2006, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.

[17]  M. Graeber,et al.  The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. , 2001, Experimental dermatology.

[18]  T Fredriksson,et al.  Severe psoriasis--oral therapy with a new retinoid. , 1978, Dermatologica.